BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 11854297)

  • 21. Requirement of Ras/MAPK pathway activation by transforming growth factor beta for transforming growth factor beta 1 production in a Smad-dependent pathway.
    Yue J; Mulder KM
    J Biol Chem; 2000 Oct; 275(40):30765-73. PubMed ID: 10843986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of bone morphogenetic protein-2 and transforming growth factor beta1 on gene expression of transcription factors, AJ18 and Runx2 in cultured osteoblastic cells.
    Takagi M; Kamiya N; Takahashi T; Ito S; Hasegawa M; Suzuki N; Nakanishi K
    J Mol Histol; 2004 Jan; 35(1):81-90. PubMed ID: 15323353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of osteogenic protein-1 (OP-1;BMP-7) and transforming growth factor-beta 1 on bone formation in vitro.
    Cheifetz S; Li IW; McCulloch CA; Sampath K; Sodek J
    Connect Tissue Res; 1996; 35(1-4):71-8. PubMed ID: 9084644
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Smad3 promotes alkaline phosphatase activity and mineralization of osteoblastic MC3T3-E1 cells.
    Sowa H; Kaji H; Yamaguchi T; Sugimoto T; Chihara K
    J Bone Miner Res; 2002 Jul; 17(7):1190-9. PubMed ID: 12096832
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protein kinase C-independent activation of protein kinase D is involved in BMP-2-induced activation of stress mitogen-activated protein kinases JNK and p38 and osteoblastic cell differentiation.
    Lemonnier J; Ghayor C; Guicheux J; Caverzasio J
    J Biol Chem; 2004 Jan; 279(1):259-64. PubMed ID: 14573624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Osthole-mediated cell differentiation through bone morphogenetic protein-2/p38 and extracellular signal-regulated kinase 1/2 pathway in human osteoblast cells.
    Kuo PL; Hsu YL; Chang CH; Chang JK
    J Pharmacol Exp Ther; 2005 Sep; 314(3):1290-9. PubMed ID: 15956019
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone morphogenetic protein-3b (BMP-3b) inhibits osteoblast differentiation via Smad2/3 pathway by counteracting Smad1/5/8 signaling.
    Matsumoto Y; Otsuka F; Hino J; Miyoshi T; Takano M; Miyazato M; Makino H; Kangawa K
    Mol Cell Endocrinol; 2012 Mar; 350(1):78-86. PubMed ID: 22155034
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transient upregulation of CBFA1 in response to bone morphogenetic protein-2 and transforming growth factor beta1 in C2C12 myogenic cells coincides with suppression of the myogenic phenotype but is not sufficient for osteoblast differentiation.
    Lee MH; Javed A; Kim HJ; Shin HI; Gutierrez S; Choi JY; Rosen V; Stein JL; van Wijnen AJ; Stein GS; Lian JB; Ryoo HM
    J Cell Biochem; 1999 Apr; 73(1):114-25. PubMed ID: 10088730
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serial passage of MC3T3-E1 cells alters osteoblastic function and responsiveness to transforming growth factor-beta1 and bone morphogenetic protein-2.
    Chung CY; Iida-Klein A; Wyatt LE; Rudkin GH; Ishida K; Yamaguchi DT; Miller TA
    Biochem Biophys Res Commun; 1999 Nov; 265(1):246-51. PubMed ID: 10548521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functions of transforming growth factor-beta family type I receptors and Smad proteins in the hypertrophic maturation and osteoblastic differentiation of chondrocytes.
    Valcourt U; Gouttenoire J; Moustakas A; Herbage D; Mallein-Gerin F
    J Biol Chem; 2002 Sep; 277(37):33545-58. PubMed ID: 12082094
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Critical role of Smads and AP-1 complex in transforming growth factor-beta -dependent apoptosis.
    Yamamura Y; Hua X; Bergelson S; Lodish HF
    J Biol Chem; 2000 Nov; 275(46):36295-302. PubMed ID: 10942775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concerted action of Smad and CREB-binding protein regulates bone morphogenetic protein-2-stimulated osteoblastic colony-stimulating factor-1 expression.
    Ghosh-Choudhury N; Singha PK; Woodruff K; St Clair P; Bsoul S; Werner SL; Choudhury GG
    J Biol Chem; 2006 Jul; 281(29):20160-70. PubMed ID: 16707491
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Opposing effects by glucocorticoid and bone morphogenetic protein-2 in fetal rat bone cell cultures.
    Centrella M; Rosen V; Wozney JM; Casinghino SR; McCarthy TL
    J Cell Biochem; 1997 Dec; 67(4):528-40. PubMed ID: 9383711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dexamethasone, BMP-2, and 1,25-dihydroxyvitamin D enhance a more differentiated osteoblast phenotype: validation of an in vitro model for human bone marrow-derived primary osteoblasts.
    Jørgensen NR; Henriksen Z; Sørensen OH; Civitelli R
    Steroids; 2004 Apr; 69(4):219-26. PubMed ID: 15183687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TGF-β and BMP signaling in osteoblast differentiation and bone formation.
    Chen G; Deng C; Li YP
    Int J Biol Sci; 2012; 8(2):272-88. PubMed ID: 22298955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biphasic effects of transforming growth factor β on bone morphogenetic protein-induced osteoblast differentiation.
    de Gorter DJ; van Dinther M; Korchynskyi O; ten Dijke P
    J Bone Miner Res; 2011 Jun; 26(6):1178-87. PubMed ID: 21611961
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Both the Smad and p38 MAPK pathways play a crucial role in Runx2 expression following induction by transforming growth factor-beta and bone morphogenetic protein.
    Lee KS; Hong SH; Bae SC
    Oncogene; 2002 Oct; 21(47):7156-63. PubMed ID: 12370805
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p38 mitogen-activated protein kinase functionally contributes to chondrogenesis induced by growth/differentiation factor-5 in ATDC5 cells.
    Nakamura K; Shirai T; Morishita S; Uchida S; Saeki-Miura K; Makishima F
    Exp Cell Res; 1999 Aug; 250(2):351-63. PubMed ID: 10413589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Smad5 and DPC4 are key molecules in mediating BMP-2-induced osteoblastic differentiation of the pluripotent mesenchymal precursor cell line C2C12.
    Nishimura R; Kato Y; Chen D; Harris SE; Mundy GR; Yoneda T
    J Biol Chem; 1998 Jan; 273(4):1872-9. PubMed ID: 9442019
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7.
    Inman GJ; Nicolás FJ; Callahan JF; Harling JD; Gaster LM; Reith AD; Laping NJ; Hill CS
    Mol Pharmacol; 2002 Jul; 62(1):65-74. PubMed ID: 12065756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.